EUVIMEDEUVIMED entdecken
Crossref

Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adults: an ERS statement

Markus Fally iD, Catia Cilloniz iD, John Linnell, Stefano Aliberti iD, Aleksandra Barac, Francesco Blasi, Alan Cumber, Phyliss Dilorenzo, George Dimopoulos, Caroline Gainer, Wouter H van Geffen, Andrea Gramegna iD und 10 weitere

European Respiratory Journal · 2026-07 · 68 (1) · 2501926

DOI: 10.1183/13993003.01926-2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 11.06.2026. Verfasst von Markus Fally und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Section for Respiratory Medicine, Zealand University Hospital - Roskilde, Roskilde, Denmark research@fally.dk. Hauptthemen laut MEDLINE: Community-Acquired Pneumonia, Healthcare-Associated Pneumonia, Cross Infection, Pneumonia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clinical trials assessing the management of pneumonia use heterogeneous outcomes, often lacking patient relevance or standardisation. We developed two core outcome sets (COSs) for future clinical trials evaluating interventions in community-acquired pneumonia (CAP) and nosocomial pneumonia (hospital-acquired pneumonia and ventilator-associated pneumonia) to improve the consistency and comparability of evidence.

Methods

A multistage, multistakeholder process was undertaken, comprising 1) a systematic review of previously used outcomes conducted by our team, 2) qualitative interviews with patients and 3) a two-round online Delphi survey involving 289 participants (patients, relatives and healthcare professionals) from 58 countries. This diverse sample ensured a broad representation of clinical and patient perspectives. Final outcomes were agreed upon through structured voting in two virtual consensus meetings in April 2025.

Results

The final COS for CAP includes: treatment success/failure, all-cause mortality, serious adverse events, readmissions (admission for community-based trials), duration of symptoms and time to clinical stability (for hospitalised patients). The nosocomial pneumonia COS includes: treatment success/failure, all-cause mortality, serious adverse events, readmission and need for ventilatory support. The panel suggested measuring mortality at 30 days from study enrolment and readmission at 30 days post-discharge.

Conclusions

These COSs, developed by a European Respiratory Society Task Force, provide a standardised framework for outcome selection in pneumonia trials and were informed by broad stakeholder input, including patients. Their use is expected to improve the relevance, quality and comparability of future research in pneumonia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Community-Acquired PneumoniaHealthcare-Associated PneumoniaCross InfectionPneumoniaHumansAdultDelphi TechniqueClinical Trials as TopicPneumonia, Ventilator-AssociatedTreatment OutcomeFemaleCommunity-Acquired InfectionsConsensusOutcome Assessment, Health CareMale

Autor:innen und Institutionen

  • Department of Internal Medicine, Section for Respiratory Medicine, Zealand University Hospital - Roskilde, Roskilde, Denmark research@fally.dk.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark.
  • Institute for Biomedical Research August Pi i Sunyer (IDIBAPS), CIBERES, Barcelona, Spain.
  • Faculty of Health Sciences, Continental University, Huancayo, Peru.
  • European Lung Foundation, Sheffield, UK.
  • Department of Biomedical Sciences, Humanitas University, Milan, Italy.

ORCID-Profile: Markus Fally, Catia Cilloniz, Stefano Aliberti, Andrea Gramegna, Clare Williams, Alexander G Mathioudakis

Zitieren

APA

Fally, M., Cilloniz, C., Linnell, J., Aliberti, S., Barac, A., Blasi, F., Cumber, A., Dilorenzo, P., Dimopoulos, G., Gainer, C., van Geffen, W. H., Gramegna, A., Hoehn, B., Polverino, E., Roger, C., Rovina, N., Stolz, D., Waterer, G., Williams, C., …, & Felton, T. W. (2026). Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adults: an ERS statement. European Respiratory Journal, 68(1), 2501926. https://doi.org/10.1183/13993003.01926-2025

Vancouver

Fally M, Cilloniz C, Linnell J, Aliberti S, Barac A, Blasi F, et al. Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adults: an ERS statement. European Respiratory Journal. 2026;68(1):2501926. doi:10.1183/13993003.01926-2025

BibTeX
@article{Fally2026,
  author = {Fally, Markus and Cilloniz, Catia and Linnell, John and Aliberti, Stefano and Barac, Aleksandra and Blasi, Francesco and Cumber, Alan and Dilorenzo, Phyliss and Dimopoulos, George and Gainer, Caroline and van Geffen, Wouter H and Gramegna, Andrea and Hoehn, Barry and Polverino, Eva and Roger, Claire and Rovina, Nikoletta and Stolz, Daiana and Waterer, Grant and Williams, Clare and Wootton, Dan and Mathioudakis, Alexander G and Felton, Timothy W},
  title = {Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adults: an ERS statement},
  journal = {European Respiratory Journal},
  year = {2026},
  volume = {68},
  number = {1},
  pages = {2501926},
  doi = {10.1183/13993003.01926-2025}
}
Kostenlos starten →